58 results
S-1/A
EX-10.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
“Disability” means, unless otherwise determined by the Committee in the applicable Award Agreement, with respect to a Participant’s Termination … , provided, however, for purposes of an Incentive Stock Option, the term Disability shall have the meaning ascribed to it under Section 22(e)(3
S-8
EX-10.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
23 Nov 20
Registration of securities for employees
5:06pm
“Disability” means, unless otherwise determined by the Committee in the applicable Award Agreement, with respect to a Participant’s Termination … , provided, however, for purposes of an Incentive Stock Option, the term Disability shall have the meaning ascribed to it under Section 22(e)(3
8-K
EX-3.2
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
of Meetings.
(a) Generally. Meetings of stockholders shall be presided over by the Chair of the Board, if any, or in the Chair’s absence or disability … , by the Chief Executive Officer, or in the Chief Executive Officer’s absence or disability, by the President, or in the President’s absence
S-1/A
EX-3.2
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
. Meetings of stockholders shall be presided over by the Chair of the Board, if any, or in the Chair’s absence or disability, by the Chief Executive … Officer, or in the Chief Executive Officer’s absence or disability, by the President, or in the President’s absence or disability, by a Vice President
S-1
EX-10.6
mr7tegr9rhw3tk nm8m
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.6
ooknne
14 Oct 20
Draft registration statement (amended)
12:00am
8-K
EX-10.9
eviuvguekvv
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
13dnyc9w1jjtnbbll9wu
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
endbg
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
DRS/A
EX-10.5
z5gy7lz l3g2wutzwl
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.4
ivt6cohpls7oi8
29 Oct 20
IPO registration
5:04pm
DRS/A
EX-10.4
re1 gsoi2dl
14 Oct 20
Draft registration statement (amended)
12:00am